GlassScriptPhysician profile
Namita Kothari
NPI 1700957594
$2,442.23
in general payments reported to CMS, 2019-2025
32 companies · $34.18 in 2025
The $34.18 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $269 · 2021: $257 · 2022: $598 · 2023: $411 · 2024: $127 · 2025: $34.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $616.96 | 2019-2023 | Da Vinci Surgical System |
| Abbvie INC. | $259.27 | 2019-2023 | |
| Gynesonics, INC. | $235.20 | 2022 | |
| Hologic Sales and Service, LLC | $206.77 | 2019-2025 | Fluent Fluid Management System, Novasure, Aptima |
| Organon LLC | $137.83 | 2021-2023 | Nexplanon |
| Medical Device Business Services, INC. | $129.54 | 2023 | |
| Myovant Sciences INC. | $96.20 | 2021-2022 | |
| Smith+Nephew, INC. | $81.47 | 2020-2021 | |
| Becton, Dickinson and Company | $58.60 | 2022-2024 | Arista Ah Flexitip |
| Coopersurgical, INC. | $49.75 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $47.39 | 2022-2023 | |
| Therapeuticsmd, INC. | $45.26 | 2019-2021 | |
| Channel Medsystems, INC. | $42.47 | 2022 | |
| Aesculap, INC. | $40.42 | 2019 | |
| Merck Sharp & Dohme LLC | $35.54 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $34.52 | 2023 | Accrufer |
| Daiichi Sankyo INC. | $33.36 | 2020-2022 | |
| Meditrina | $30.98 | 2022 | |
| Aspira Women'S Health INC | $25.05 | 2023 | Ova1 |
| Medtronic, INC. | $25.00 | 2024 | Venaseal |
| Roche Diagnostics Corporation | $24.08 | 2019 | |
| Exeltis, USA INC. | $22.96 | 2020 | |
| Pfizer INC. | $19.53 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.75 | 2021 | |
| Astellas Pharma US INC | $18.74 | 2024 | Veozah |
| Monaghan Medical Corporation | $18.28 | 2023 | Aeroeclipse |
| Baxter Healthcare | $17.94 | 2024 | Perclot |
| Covidien LP | $17.26 | 2019 | |
| Optumhealth Care Solutions, LLC | $16.31 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Lupin INC. | $13.27 | 2020 | |
| Boston Scientific Corporation | $12.17 | 2019 | |
| Allergan, INC. | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Namita Kothari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.